Pfizer, Inc. vs TransMedics Group, Inc. — Stock Comparison

PFE
Pfizer, Inc.
$26.33
▼ 1.39%
vs
TMDX
TransMedics Group, Inc.
$100.01
▼ 0.77%
Q·Score Winner
TransMedics Group, Inc.
TMDX8.8/10vs 6.5/10

Q·Score Breakdown

6.5
Neutral
Overall
8.8
Very Bullish
7.4
Quality
9.3
7
Health
8.2
5.6
Growth
10
6.7
Valuation
8.4
5.2
Sentiment
7.8
PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

TMDX

Earnings growing 1188% year-over-year on 32% revenue growth.

Analyst Consensus

HOLD
Target $29.00 (+10.2%)
27 analysts
BUY
Target $156.00 (+56.0%)
10 analysts

Fundamentals

PFE
TMDX
19.4×
Trailing P/E
20.5×
9.4×
Forward P/E
27.2×
12.4%
Profit Margin
31.4%
75.8%
Gross Margin
59.9%
8.9%
ROE
54.2%
-1.2%
Revenue Growth
32.2%
Earnings Growth
1188.1%
0.39
Beta
2.08
Price / Book
$149.8B
Market Cap
$3.5B
$22 – $29
52-Week Range
$90 – $156

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →